Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/28/2012US20120165270 Inhibition of hair follicle growth by the wnt inhibitor dkk1
06/28/2012US20120165269 Tumor Cell-Killing Peptides
06/28/2012US20120165268 P53 fusion proteins and methods of making and using thereof
06/28/2012US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF
06/28/2012US20120165266 Method for preparing gintonin, which is a novel glycolipoproetin from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method
06/28/2012US20120165265 Calcium Signaling Modulators Involving STIM and ORAI Proteins
06/28/2012US20120165264 Degradation-Stabilised, Biocompatible Collagen Matrices
06/28/2012US20120165263 Bone regeneration agent comprising gelatin
06/28/2012US20120165262 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
06/28/2012US20120165261 Alpha-1-antitrypsin compositions
06/28/2012US20120165260 Crystalline ezatiostat hydrochloride ansolvate
06/28/2012US20120165259 Agent for ameliorating blood-brain barrier disorders
06/28/2012US20120165258 Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets
06/28/2012US20120165257 Compositions and methods for treating joints
06/28/2012US20120165256 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses
06/28/2012US20120165255 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/28/2012US20120165254 Sulphated hyaluronic acid for treating degenerative osteoarthritis
06/28/2012US20120165253 Pharmaceutical composition for inhibiting peritoneal dissemination
06/28/2012US20120165252 Method of Regulating Glucose Metabolism, and Reagents Related Thereto
06/28/2012US20120165251 Diabetes therapy
06/28/2012US20120165250 Active Cores of Peptide Triazole HIV-1 Entry Inhibitors
06/28/2012US20120165249 Stabilized Therapeutic Small Helical Antiviral Peptides
06/28/2012US20120165248 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
06/28/2012US20120165246 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
06/28/2012US20120165245 Angiogenically effective unit dose of fgf and method of administering
06/28/2012US20120165244 Methods for binding lewis y antigen
06/28/2012US20120165243 Use of dietary fibres against muscle wasting
06/28/2012US20120164265 Dietary Method for Modulating Glucose Metabolism
06/28/2012US20120164234 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
06/28/2012US20120164231 Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates
06/28/2012US20120164229 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
06/28/2012US20120164186 Diketopiperazine Microparticles with Defined Specific Surface Areas
06/28/2012US20120164183 Method for detection and treatment of aneurysms
06/28/2012US20120164181 Non-Specific Immunostimulating Agents
06/28/2012US20120164166 Neisseria meningitidis antigens and compositions
06/28/2012US20120164163 Cdc45l peptides and vaccines including the same
06/28/2012US20120164157 Method of treating stroke with thrombolytic agent
06/28/2012US20120164147 Mammalian genes; related reagents and methods
06/28/2012US20120164145 H. pylori lipopolysaccharide outer core epitope
06/28/2012US20120164142 Compositions comprising natriuretic peptides and methods of use thereof
06/28/2012US20120164141 Methods and compositions for inducing apoptosis
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164136 Compositions and Methods for Treatment of Cancer by Disrupting the LH/LHR Signaling Pathway
06/28/2012US20120164134 Sugar-free chewable supplement
06/28/2012US20120164131 Modified mutant collagenase and it's use in fat melting and in scar reduction
06/28/2012US20120164130 Modified Factor IX Polypeptides and Uses Thereof
06/28/2012US20120164129 Expression of thrombin variants
06/28/2012US20120164128 Means and methods for counteracting polyq expansion disorders
06/28/2012US20120164127 Mirac proteins
06/28/2012US20120164126 Proteins for use in human and animal staphyococcus infections
06/28/2012US20120164125 Nucleic acid cleaving agent
06/28/2012US20120164124 Phage-associated lytic enzymes for treatment of bacillus anthracis and related conditions
06/28/2012US20120164123 Method for the treatment of pulmonary disease and method of producing proteins of use therein
06/28/2012US20120164120 Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
06/28/2012US20120164115 Methods related to surgery
06/28/2012US20120164111 Novel post-translational fibrinogen variants
06/28/2012US20120164108 Virus strains
06/28/2012US20120164104 Composition and Methods of Treating Viral Infections and Viral Induced Tumors
06/28/2012US20120164103 Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
06/28/2012US20120164102 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
06/28/2012US20120164101 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
06/28/2012US20120164100 Temperature sensitive hydrogel and block copolymers
06/28/2012US20120164099 Use of human prostate cell lines in cancer treatment
06/28/2012US20120164087 Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions
06/28/2012US20120164076 Methods of treatment using thymus-derived compositions
06/28/2012US20120164074 Methods of diagnosing, preventing and treating cancer metastasis
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164071 Compositions and Methods Comprising Phosphatidylethanolamine-Binding Peptide Derivatives
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012US20120164065 Method and composition for treating cancer
06/28/2012CA2822745A1 A composition comprising at least to compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
06/28/2012CA2822732A1 Antimicrobial agents
06/28/2012CA2822617A1 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
06/28/2012CA2822559A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses
06/28/2012CA2822460A1 Peptides for treating cancer
06/28/2012CA2822442A1 Cyclic crf antagonist peptides
06/28/2012CA2822385A1 Anti-inflammatory proteins and methods of preparation and use thereof
06/28/2012CA2822350A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012CA2822097A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine
06/28/2012CA2821969A1 Tear substitutes
06/28/2012CA2821807A1 Methods and compositions suitable for managing blood glucose in animals
06/28/2012CA2821766A1 Glucagon analogs exhibiting gip receptor activity
06/28/2012CA2821378A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
06/28/2012CA2821372A1 Upar-antagonists and uses thereof
06/28/2012CA2820781A1 Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
06/27/2012EP2468868A1 Chemotherapeutic sensitizers
06/27/2012EP2468865A1 Antisense oligonucleotide modulation of stat3 expression
06/27/2012EP2468863A1 Therapeutic peptides
06/27/2012EP2468858A1 Fusion protein regulating plasma glucose and lipid, its preparation method and use
06/27/2012EP2468856A1 Antimicrobial Agents
06/27/2012EP2468765A1 Multimer of extracellular domain of cell surface functional molecule
06/27/2012EP2468763A2 HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468294A1 A method of modulating cellular activity and agents for use therein
06/27/2012EP2468293A1 Use of pegylated il-10 to treat cancer
06/27/2012EP2468292A1 Antisecretory factors for treating intraocular hypertension
06/27/2012EP2468291A1 Activin-ActRII Antagonists and Uses for Increasing Red Blood Cell Levels
06/27/2012EP2468290A1 Activin-ActRII Antagonists and Uses for Increasing Red Blood Cell Levels
06/27/2012EP2468289A1 Peptides derived from plasminogen activator inhibitor-1 and uses thereof
06/27/2012EP2468288A1 Peptides for treating cancer
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 3163